Liver enzymes and type 2 diabetes: A complex two-way relationship

Journal of Diabetes and its Complications

Volumn 27, Issue 4, 2013, Pages 301-302

  Kramer, Caroline K ^a   Retnakaran, Ravi ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTISENSE OLIGONUCLEOTIDE; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME; METFORMIN PLUS ROSIGLITAZONE; TRIACYLGLYCEROL LIPASE;

BLOOD LEVEL; DYSLIPIDEMIA; EDITORIAL; FATTY LIVER; FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER DYSFUNCTION; LIVER FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETES MELLITUS; FEMALE; HUMANS; LIVER; LIVER DISEASES; MALE;

EID: 84879966231     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.04.009     Document Type: Editorial

References (15)

1. J.M. Brown, J.L. Betters, and C. Lord CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance Journal of Lipid Research 51 2010 3306 3315
2. A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G. Davey Smith, and D.A. Lawlor Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: The British Women's Heart and Health Study and meta-analysis Diabetes Care 32 2009 741 750
3. A.J. Hanley, K. Williams, and A. Festa Elevations in markers of liver injury and risk of type 2 diabetes: The insulin resistance atherosclerosis study Diabetes 53 2004 2623 2632
4. S.E. Inzucchi, R.M. Bergenstal, and J.B. Buse Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 55 2012 1577 1596
5. C.Y. Jeon, C.K. Roberts, C.M. Crespi, and Z. Zhang Elevated liver enzymes in individuals with undiagnosed diabetes in the U.S Journal of Diabetes and Its Complication 27 2013 333 339
6. K. Kantartzis, A. Peter, and F. Machicao Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene Diabetes 58 2009 2616 2623
7. C. Lorenzo, A.J. Hanley, M.J. Rewers, and S.M. Haffner The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: The Insulin Resistance Atherosclerosis Study Diabetologia 56 2013 746 757
8. M. Monetti, M.C. Levin, and M.J. Watt Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver Cell Metabolism 6 2007 69 78
9. M.O. Rakoski, A.G. Singal, M.A. Rogers, and H. Conjeevaram Meta-analysis: Insulin sensitizers for the treatment of non-alcoholic steatohepatitis Alimentary Pharmacology and Therapeutics 32 2010 1211 1221
10. R. Retnakaran, C. Ye, A.J. Hanley, S.B. Harris, and B. Zinman Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance Diabetes, Obesity & Metabolism 14 2012 91 93
11. S. Romeo, J. Kozlitina, and C. Xing Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nature Genetics 40 2008 1461 1465
12. N. Stefan, H. Staiger, and H.U. Haring Dissociation between fatty liver and insulin resistance: The role of adipose triacylglycerol lipase Diabetologia 54 2011 7 9
13. G. Targher, and C.D. Byrne Nonalcoholic fatty liver disease: A novel cardiometabolic risk factor for type 2 diabetes and its complications The Journal of Clinical Endocrinology and Metabolism 98 2013 483 495
14. S.M. Turpin, A.J. Hoy, and R.D. Brown Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice Diabetologia 54 2011 146 156
15. B. Zinman, S.B. Harris, and J. Neuman Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): A double-blind randomised controlled study The Lancet 376 2010 103 111